Avigen, Inc - logo
Avigen Reports Second Quarter 2009 Financial Results
August 10, 2009 12:59 ET | Avigen, Inc.
ALAMEDA, Calif., Aug. 10, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company, today reported financial results for its second quarter ended June 30, 2009. At June 30,...
Avigen, Inc - logo
Avigen Granted AV411 Patent for Neuropathic Pain
May 20, 2009 08:00 ET | Avigen, Inc.
ALAMEDA, Calif., May 20, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company, announced today that it has been granted United States Patent No. 7,534,806, entitled "Method...
Avigen, Inc - logo
Avigen Reports First Quarter 2009 Financial Results
May 11, 2009 08:00 ET | Avigen, Inc.
ALAMEDA, Calif., May 11, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company, today reported financial results for its first quarter ended March 31, 2009. At March 31,...
Avigen, Inc - logo
Avigen's Stockholders Deny BVF's Bid to Remove Board of Directors in Proxy Fight
March 31, 2009 08:00 ET | Avigen, Inc.
ALAMEDA, Calif., March 31, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, today announced that based on the final tabulation of votes reported by the independent...
Avigen, Inc - logo
Avigen Board Discontinues Strategic Merger Discussions to Develop a Plan for Liquidation
March 26, 2009 09:21 ET | Avigen, Inc.
ALAMEDA, Calif., March 26, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, today announced that its Board of Directors has discontinued its strategic merger...
Avigen, Inc - logo
Leading Independent Advisory Service Urges Avigen Stockholders to Reject BVF's Proposal
March 18, 2009 14:40 ET | Avigen, Inc.
ALAMEDA, Calif., March 18, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, today announced that its Board of Directors issued the following comments in a letter to...
Avigen, Inc - logo
Avigen's Board Urges Stockholders to Reject BVF's Proposal
March 11, 2009 08:00 ET | Avigen, Inc.
ALAMEDA, Calif., March 11, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, today announced that it has scheduled a Special Meeting of Stockholders as requested by...
Avigen, Inc - logo
Avigen Announces Positive Data for AV411 in Pain Relief and Drug Addiction
February 25, 2009 08:00 ET | Avigen, Inc.
ALAMEDA, Calif., Feb. 25, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, announced today that two preclinical reports with glial attenuator AV411 (ibudilast) support...
Avigen, Inc - logo
Avigen Reports 2008 Financial Results and Updates Progress On Strategic Review
February 11, 2009 08:00 ET | Avigen, Inc.
ALAMEDA, Calif., Feb. 11, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, today reported financial results for its fourth quarter and year ended December 31, 2008. At...
Avigen, Inc - logo
Avigen Board Rejects BVF Offer as Inadequate
February 06, 2009 08:00 ET | Avigen, Inc.
Recommends Stockholders Not Tender Shares Company Reviewing Strategic Alternatives ALAMEDA, Calif., Feb. 6, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a...